|
 |
|||||||||
 |
||||||||||
17.05.2013
Biofronterra publishes 1st quarter 2013 interim report
(1 Download)
13.05.2013
Santhera's Shareholders Support Business Continuation and Evaluation of Strategic Options
(1 Download)
16.04.2013
Independent DSMB Recommends Continuation of Santhera's Phase III Trial of Catena in Duchenne Muscular Dystrophy
(1 Download)
15.04.2013
Santhera Reports 2012 Financial Figures and Announces Restructuring
(1 Download)
15.04.2013
Biofrontera AG publishes financial results for 2012
(1 Download)
|
